Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MYCN and Metabolic Reprogramming in Neuroblastoma

Cancers(2022)10.3390/cancers14174113Source: DataRank Database

MYCN and Metabolic Reprogramming in Neuroblastoma is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access48 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.18)OA: goldTopics (23)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Anamika Gupta,Han‐Fei Ding ORCID,Mohit Bansal ORCID

Live enrichment

PubMed:36077650 PMC:PMC9455056 OpenAlex:https://openalex.org/W4293104093

National Institutes of Health

Grant: R01CA190429

National Institutes of Health

Grant: R01CA236890

National Institutes of Health

Grant: 5R01CA236890-04

Linking nucleotide and amino acid metabolism to cholesterol synthesis by MYCN

National Institutes of Health

Grant: 5R01CA190429-04

Epigenetic regulation of cancer metabolism by G9A

FWCI

5.18

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/14/17/4113/pdf?version=1661929745

publisherhttps://www.mdpi.com/2072-6694/14/17/4113/pdf?version=1661929745

publisherhttps://www.mdpi.com/2072-6694/14/17/4113/pdf

journalhttps://doi.org/10.3390/cancers14174113

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36077650

Fields of Study

Neuroblastoma Research and TreatmentsCancer, Hypoxia, and MetabolismPancreatic function and diabetes0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

NeuroblastomaReprogrammingPediatric cancerCancer researchCatabolismCancerBiologyBioinformaticsCellMetabolismEndocrinologyGeneticsCell cultureCancer MetabolismMycnMetabolic ReprogrammingReview

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN

10.6084/m9.figshare.24187880.v1figshare

Additional file 1 of LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN

10.6084/m9.figshare.24187880figshare

Additional file 4 of LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN

10.6084/m9.figshare.24187889.v1figshare

Additional file 4 of LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN

10.6084/m9.figshare.24187889figshare

Additional file 3 of LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN

10.6084/m9.figshare.24187886.v1figshare